🔗 Share this article

An underground economy for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Popularity Online

Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Followers are urged to message these profiles privately for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and assertions of next-day British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Worries

However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to users injecting products of uncertain source.

Some experts said the demand for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Material Removal

Based on the social media company, the service has taken down violative material and prohibited associated keywords and query recommendations. The company said it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at residence.

After moments of joining one group, a vendor posted WhatsApp details, where most purchases take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Inside these groups, messages display black plastic parcels with Royal Mail stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how long a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they cannot confirm. Although the science behind this drug is valid, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in demand to recent cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational product not yet authorized … may expose patients to possibly significant health risks”.